Literature DB >> 25331742

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.

Shang-Yi A Tsai1, Michael J Pokrass, Neal R Klauer, Nicole E De Credico, Tsung-Ping Su.   

Abstract

INTRODUCTION: Sigma-1 receptors (Sig-1Rs) are molecular chaperones that reside mainly in the endoplasmic reticulum (ER) but exist also in the proximity of the plasma membrane. Sig-1Rs are highly expressed in the CNS and are involved in many cellular processes including cell differentiation, neuritogenesis, microglia activation, protein quality control, calcium-mediated ER stress and ion channel modulation. Disturbance in any of the above cellular processes can accelerate the progression of many neurological disorders; therefore, the Sig-1R has been implicated in several neurological diseases. AREAS COVERED: This review broadly covers the functions of Sig-1Rs including several neurodegenerative disorders in humans and drug addiction-associated neurological disturbance in the case of HIV infection. We discuss how several Sig-1R ligands could be utilized in therapeutic approaches to treat those disorders. EXPERT OPINION: Emerging understanding of the cellular functions of this unique transmembrane chaperone may lead to the use of new agents or broaden the use of certain available ligands as therapeutic targets in those neurological disorders.

Entities:  

Keywords:  Alzheimer’s disease; HIV-associated neurodementia; Parkinson’s disease; amyotrophic lateral sclerosis; frontotemporal lobar degeneration; neurodegenerative diseases; psychiatric disorders; sigma-1 receptor

Mesh:

Substances:

Year:  2014        PMID: 25331742      PMCID: PMC5518923          DOI: 10.1517/14728222.2014.972939

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  117 in total

1.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

2.  Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.

Authors:  Agnes A Luty; John B J Kwok; Carol Dobson-Stone; Clement T Loy; Kirsten G Coupland; Helena Karlström; Tomasz Sobow; Joanna Tchorzewska; Aleksandra Maruszak; Maria Barcikowska; Peter K Panegyres; Cezary Zekanowski; William S Brooks; Kelly L Williams; Ian P Blair; Karen A Mather; Perminder S Sachdev; Glenda M Halliday; Peter R Schofield
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

3.  Afobazole activation of σ-1 receptors modulates neuronal responses to amyloid-β25-35.

Authors:  Adam A Behensky; Ilya E Yasny; Alexander M Shuster; Sergei B Seredenin; Andrey V Petrov; Javier Cuevas
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

4.  A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist.

Authors:  G Skuza; Z Rogóz
Journal:  Behav Pharmacol       Date:  2002-11       Impact factor: 2.293

5.  Association analysis of SIGMAR1 with major depressive disorder and SSRI response.

Authors:  Taro Kishi; Reiji Yoshimura; Tomo Okochi; Yasuhisa Fukuo; Tsuyoshi Kitajima; Takenori Okumura; Tomoko Tsunoka; Kunihiro Kawashima; Yoshio Yamanouchi; Yoko Kinoshita; Wakako Umene-Nakano; Hiroshi Naitoh; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuropharmacology       Date:  2010-02-21       Impact factor: 5.250

Review 6.  Antidepressant treatment of psychotic major depression: potential role of the sigma receptor.

Authors:  Stephen M Stahl
Journal:  CNS Spectr       Date:  2005-04       Impact factor: 3.790

7.  Anti-amnesic effect of dimemorfan in mice.

Authors:  Hui-Hung Wang; Jyh-Wei Chien; Yueh-Ching Chou; Jyh-Fei Liao; Chieh-Fu Chen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 8.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

9.  The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study.

Authors:  T A Mavlyutov; M L Epstein; K A Andersen; L Ziskind-Conhaim; A E Ruoho
Journal:  Neuroscience       Date:  2010-02-16       Impact factor: 3.590

10.  Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.

Authors:  Tomohisa Mori; Teruo Hayashi; Eri Hayashi; Tsung-Ping Su
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

View more
  23 in total

Review 1.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

Authors:  Tsung-Ping Su; Tzu-Chieh Su; Yoki Nakamura; Shang-Yi Tsai
Journal:  Trends Pharmacol Sci       Date:  2016-02-09       Impact factor: 14.819

2.  Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.

Authors:  Chelsy R Eddings; Nicolas Arbez; Sergey Akimov; Michal Geva; Michael R Hayden; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2019-05-17       Impact factor: 5.996

Review 3.  Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Shona Mookerjee; Nidhi Kaushal; Rae R Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

5.  Sigma-1 receptor agonist increases axon outgrowth of hippocampal neurons via voltage-gated calcium ions channels.

Authors:  Dong Li; Shu-Zhuo Zhang; Yu-Hong Yao; Yun Xiang; Xiao-Yun Ma; Xiao-Li Wei; Hai-Tao Yan; Xiao-Yan Liu
Journal:  CNS Neurosci Ther       Date:  2017-10-08       Impact factor: 5.243

6.  Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.

Authors:  Shang-Yi A Tsai; Michael J Pokrass; Neal R Klauer; Hiroshi Nohara; Tsung-Ping Su
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

7.  Sigma-1 Receptor Alleviates Airway Inflammation and Airway Remodeling Through AMPK/CXCR4 Signal Pathway.

Authors:  Te Jiang; Di Zhao; Zhiyuan Zheng; Zhankui Li
Journal:  Inflammation       Date:  2022-01-14       Impact factor: 4.092

8.  Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation.

Authors:  Michael A Wheeler; Merja Jaronen; Ruxandra Covacu; Stephanie E J Zandee; Giulia Scalisi; Veit Rothhammer; Emily C Tjon; Chun-Cheih Chao; Jessica E Kenison; Manon Blain; Vijayaraghava T S Rao; Patrick Hewson; Andreia Barroso; Cristina Gutiérrez-Vázquez; Alexandre Prat; Jack P Antel; Russ Hauser; Francisco J Quintana
Journal:  Cell       Date:  2019-01-17       Impact factor: 41.582

Review 9.  Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.

Authors:  Ning-Hua Wu; Yu Ye; Bin-Bin Wan; Yuan-Dong Yu; Chao Liu; Qing-Jie Chen
Journal:  Mol Neurobiol       Date:  2021-08-12       Impact factor: 5.590

Review 10.  Knocking Out Sigma-1 Receptors Reveals Diverse Health Problems.

Authors:  Simon Couly; Nino Goguadze; Yuko Yasui; Yuriko Kimura; Shao-Ming Wang; Nino Sharikadze; Hsiang-En Wu; Tsung-Ping Su
Journal:  Cell Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.